Medical cannabis reciprocity, state by state: which cards travel, which do not, and what happens if you cross a state line with product

"Reciprocity" is the term US medical-cannabis programs use to describe whether they recognize medical cards issued by other states. It sounds simple. In practice, the rules are a patchwork that produces three categories of state behavior, several edge cases, and one structural constant: federal law prohibits transporting cannabis across state lines regardless of state-level recognition.

This article maps the matrix as it stands in May 2026. Use the table as a starting reference, then verify against the destination state's health-department page before making travel plans that depend on cannabis access.

The three reciprocity postures

State medical-cannabis programs sort into three categories:

1. Purchase reciprocity (full reciprocity)

The destination state allows visiting patients holding a valid out-of-state medical card to purchase from licensed dispensaries in the destination state. The visiting patient typically must present the out-of-state card plus a matching state-issued ID. Some states require advance registration; others accept walk-in presentation.

States with purchase reciprocity in May 2026:

• Arkansas — issues a 90-day visiting patient card for a fee; recognition extends only to conditions on Arkansas's qualifying list.
• District of Columbia — accepts out-of-state cards for purchase from DC dispensaries.
• Hawaii — operates a "329V" out-of-state patient registration program through the Hawaii Department of Health; patients register before travel and receive a Hawaii recognition card.
• Maine — accepts out-of-state cards for adult patients.
• Nevada — accepts out-of-state cards directly at the dispensary with valid ID; no advance registration required.
• New Hampshire — accepts out-of-state cards for purchase from NH dispensaries (with some restrictions).
• New Mexico — accepts out-of-state cards for purchase from NM dispensaries (and authorizes its own reciprocal program).
• Oklahoma — operates a temporary medical license for out-of-state patients, issued for 30 to 60 days for a fee through OMMA's online portal; once issued, the patient may purchase from any Oklahoma dispensary.
• Puerto Rico and US Virgin Islands — accept out-of-state cards.
• Rhode Island — accepts out-of-state cards for adult patients with valid documentation.
• Utah — accepts out-of-state cards with some condition-list and product-form constraints.

Note that several of these states have effectively been superseded by adult-use legalization for non-medical-specific purposes. In Nevada, New Mexico, Maine, Rhode Island, and DC, an adult 21+ can also purchase from licensed adult-use retail without any medical card at all.

2. Possession-only recognition

The destination state acknowledges out-of-state cards as protection against state criminal-possession penalties up to the destination state's cap, but does not allow purchase from local dispensaries. The visiting patient must already have product on hand (which is itself problematic — see the interstate-transport section below).

States with possession-only recognition (subject to product, quantity, and condition constraints):

• Arizona — recognizes valid out-of-state cards for possession.
• Mississippi — limited possession recognition.
• Missouri — recognizes for possession.
• Pennsylvania — does not allow purchase but provides some patient protection for possession of products lawfully obtained in the patient's home state.

These rules typically come with significant restrictions:

• The visiting patient must hold a valid card issued by another US medical-cannabis program.
• The product must be in original packaging and within possession limits matching the destination state's caps.
• The condition certified by the visiting patient's home state must (in some states) match a qualifying condition under the destination state's program.

3. No reciprocity

The destination state does not recognize out-of-state medical cards in any form. Visiting patients are subject to the same criminal-possession rules as any non-patient resident of the destination state.

States with no reciprocity:

• Florida (notable for largest medical patient population) — only recognizes its own state-issued cards.
• New York — does not recognize out-of-state cards for purchase or possession-protection purposes.
• California — surprisingly, does not formally recognize out-of-state medical cards; adult-use availability since 2018 makes this largely a moot question for 21+ visitors.
• Texas — Compassionate Use Program is closed to non-Texas patients.
• Illinois — does not allow out-of-state cards for purchase; adult-use is available since 2020.
• New Jersey, Connecticut, Massachusetts, Maryland — comprehensive medical programs without formal reciprocity (most have adult-use available to 21+ visitors).
• Ohio, Michigan — no medical reciprocity (adult-use available).
• Most southern states — Alabama, Georgia, Louisiana, North Carolina, South Carolina, Tennessee, Virginia (medical), West Virginia, Kentucky — no reciprocity for either purchase or possession.

The reciprocity matrix at a glance

A simplified summary of the most-asked-about reciprocity pairings:

Visitor's home program	Travels to	Reciprocity status
Florida MMJ card	Nevada	Purchase reciprocity
Florida MMJ card	Oklahoma	Temporary license available
Florida MMJ card	New York	No reciprocity (use adult-use 21+)
Florida MMJ card	Maryland	No reciprocity (use adult-use 21+)
New York MMJ card	Florida	No reciprocity at all
Pennsylvania MMJ card	Maryland	No reciprocity (use adult-use 21+)
Pennsylvania MMJ card	Ohio	No reciprocity (use adult-use 21+)
Texas TCUP patient	Oklahoma	Temporary license available
Texas TCUP patient	New Mexico	Purchase reciprocity available
Any MMJ patient	DC	Purchase reciprocity
Any MMJ patient	Hawaii	329V registration available

The pattern: medical reciprocity matters most when traveling between two medical-only states. For travel between a medical state and an adult-use state, the adult-use option (for 21+ visitors) is generally simpler.

The interstate transport problem

The hardest constraint is one no state can change: federal law prohibits the interstate transport of cannabis, period. The April 2026 DOJ Schedule III order did not authorize interstate commerce. Crossing a state line with cannabis (even between two states where the patient is fully legal in each state individually) remains a federal Controlled Substances Act violation.

Practical implications:

• Driving from a state where you are a registered medical patient into a neighboring state with reciprocity does not legalize the transport itself. The product is technically illegal during the journey.
• Federal interdiction (highway patrol stops, Customs and Border Protection within the 100-mile border zone, federal-land enforcement on federal highways) can produce federal charges even if both states would treat the substance as legal.
• Air travel within domestic US airspace is governed by TSA (federal). TSA's stated posture is that medical-cannabis products and adult-use cannabis remain prohibited in carry-on and checked luggage; TSA agents who encounter cannabis refer the matter to local airport law enforcement, whose response varies by jurisdiction.

The practical implication for reciprocity-state visitors: arrive without cannabis. Purchase in the destination state under whatever reciprocity or adult-use option applies. Consume in the destination state. Do not transport leftover product back across the state line.

States that have evolved their reciprocity since 2024

Several state programs have updated their reciprocity rules in the last 18 months:

• Oklahoma — has continuously refined its temporary visitor license program, with fees and validity periods adjusted by OMMA rule.
• Hawaii — the 329V out-of-state registration program has evolved to handle higher volumes.
• Several adult-use states — as adult-use availability has expanded, formal medical reciprocity has become less politically pressing in those states. The de facto reciprocity is 21+ adult-use availability.
• Some smaller medical-only states — have quietly tightened reciprocity in response to enforcement concerns.

The federal-level question (whether April 2026 rescheduling will trigger a national reciprocity framework) is unresolved. The DOJ order is explicitly limited to "state medical marijuana license" status; it does not preempt state-level decisions about whether to recognize other states' cards.

What patients should do before traveling

Five practical steps:

1. Verify the destination state's current rule on its state health-department page (not on a third-party site). Reciprocity policies have changed multiple times in recent years.
2. Confirm whether you need to pre-register with the destination state's program (Oklahoma, Hawaii). Pre-registration takes 1 to 10 business days.
3. Identify a licensed dispensary in the destination state and confirm its acceptance policy for visiting patients (some local dispensaries may have additional documentation requirements).
4. Plan to leave product behind. Even if reciprocity makes purchasing legal in the destination state, transport back across state lines is not legalized by either state.
5. Carry your home-state card and matching ID in original-issuance form. Photocopies and screenshots may not satisfy the destination state's verification requirements.

What reciprocity does not solve

Even where formal reciprocity exists, several patient concerns remain unresolved:

• Product availability. A visiting patient may not find equivalent products in the destination state's market (THC concentrations, edible doses, and product forms vary substantially state to state).
• Possession limits. The destination state's possession caps apply, regardless of what the patient's home state permits.
• Public consumption rules. Where you can legally consume varies by state and by jurisdiction within the state.
• Federal property and federally regulated activities. Reciprocity does nothing for federal employment, security clearance, DOT-regulated driving, or use on federal property.

For a more comprehensive treatment of how state medical-cannabis status interacts with federal law, see the companion article on federal employment.

The federal-rescheduling question for reciprocity

A natural question arising from the April 22, 2026 Schedule III order: does federal rescheduling create a path to national reciprocity for state medical-cannabis cards? The current answer is no.

The DOJ order recognizes state medical-cannabis licenses as a federal-controlled-substance category, but does not impose any cross-state recognition requirement. Each state remains free to choose whether to recognize other states' medical cards, on what terms, and for what purposes. The federal change addresses the operator-side regulatory and tax posture, not the patient-side travel question.

For a national reciprocity framework to emerge, one of three things would need to happen:

1. Congressional legislation specifically authorizing or requiring cross-state recognition of state medical-cannabis cards. No such bill has advanced in the 119th Congress.
2. Interstate compacts between groups of states, similar to the Nurse Licensure Compact or the Driver License Compact. No serious interstate cannabis compact effort has emerged from any state-AG association or governors' organization as of May 2026.
3. Bilateral state-to-state agreements that formalize what currently exists as informal recognition. A few state regulators have explored these conversations, but none has produced a binding agreement.

The structural barriers to any of these are real. State medical-cannabis programs are funded by state-program fees and taxed under state-specific rules; cross-state recognition raises tax-collection and program-funding questions that have not been addressed in any current legislative draft.

Special cases: tribal lands and federal facilities

Two additional jurisdictional complications worth noting:

Tribal lands. Federally recognized Native American tribes operate cannabis-policy frameworks that are independent of state law. Several tribes (including in California, Nevada, Washington, and the Dakotas) operate licensed cannabis dispensaries on tribal land. Whether a visiting state-medical-cardholder can purchase from a tribal dispensary depends on the specific tribe's rules and the tribal-state agreements in place. A few tribes operate visitor-reciprocity programs analogous to state reciprocity; others restrict purchase to enrolled tribal members.

Federal facilities. National parks, military bases, federal courthouses, post offices, and other federally controlled property remain subject to federal law regardless of the surrounding state's status. The April 2026 rescheduling did not change this. A medical-cannabis cardholder traveling through a national park or visiting a federal facility is subject to federal cannabis rules on that property, even if both the home state and surrounding state are legalized.

For patients planning travel, the simplest rule of thumb: if you are 21+ and your destination is a recreational-legal state, use the recreational-retail option. If your destination is medical-only and offers reciprocity, follow the destination state's specific registration or walk-in process. If your destination has no reciprocity and no adult-use availability, plan a cannabis-free trip.

[Last reviewed 2026-05-18. This is informational only — not medical or legal advice. Verify current rules with the destination state's health department before traveling.]